A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...
(“Alpha”) of the improved new drug ZUNVEYL(benzgalantamine delayed-release tablets)(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s type. The Group is ...
(“Alpha”) of the improved new drug ZUNVEYL(benzgalantamine delayed-release tablets)(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s ty ...
Meanwhile, trial results suggest the new drugs could instead ... capacity and knowledge of dementia in those places. Experts believe 40% of Alzheimer’s cases could already be prevented by ...
The study also integrates drug databases ... New Brain Mapping ... brain that are hallmarks of Alzheimer's disease up to 20 years before the earliest symptoms of dementia ...
19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease ... dementia, according to a new ...